THEMIS MEDICARE LTD.

Themis Medicare Limited reported its investor presentation for the quarter ended June 30, 2026. Management stated that consolidated revenue for Q1 FY27 was ₹86.96 crore, with a significant improvement in profitability, as Profit Before Tax (PBT) reached ₹38.6 crore compared to a loss of ₹14.1 crore in Q1 FY26. Profit After Tax (PAT) was ₹24.6 crore, resulting in a PAT margin of 28.3%. The critical care business experienced growth due to focused brand promotion, while the API and institution business showed promising recovery. Management emphasized the importance of cash flow management and cost optimization. R&D investments were reported at around 8% of revenue, reflecting a commitment to product development. The presentation outlined a strategic focus on enhancing profitability and cash flow through operational efficiencies and a stronger presence in hospital and API businesses.

Management highlighted improvements in profitability and growth in key business segments.